1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis : A presymptomatic case–control study
(
- Contribution to journal › Article
-
Mark
Systemic inflammation and risk of multiple sclerosis – A presymptomatic case-control study
(
- Contribution to journal › Article
- 2021
-
Mark
Leptin levels are associated with multiple sclerosis risk
(
- Contribution to journal › Article
-
Mark
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study
(
- Contribution to journal › Article
- 2020
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article
-
Mark
Infection Risks among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
(
- Contribution to journal › Article
- 2014
-
Mark
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
(
- Contribution to journal › Article
- 2013
-
Mark
Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish population
(
- Contribution to journal › Article